Meiqun Cao

1.3k citations
23 papers · 900 indexed · 1 hit paper · h-index 13
Topics
Traditional Chinese Medicine Studies (3 papers)Alzheimer's disease research and treatments (3 papers)Salivary Gland Disorders and Functions (3 papers)
Partner nations
ChinaHong KongLebanon

In The Last Decade

Meiqun Cao

21 papers receiving 891 citations

Hit Papers

Nanomedicine in cancer therapy20232026202420252023100200300400

Peers

Meiqun Cao
Comparison fields: 5 of 103
  • Molecular Biology 332
  • Biomedical Engineering 268
  • Biomaterials 198
  • Immunology 119
  • Oncology 115
Replace Lan Yang with:
Lan Yang China
Xinhua Xia China
Jibiao Wu China
Gaona Shi China
Jisu Kim South Korea
Qin Tian China
Ruoning Wang China
Meiqun Cao relative to Lan Yang China Lan Yang's profile →
Citations per field
00.5×1.5×2.3×
Lan Yang · 1×
Citations per year

Countries citing papers authored by Meiqun Cao

Since Specialization
Citations

This map shows the geographic impact of Meiqun Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiqun Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiqun Cao more than expected).

Fields of papers citing papers by Meiqun Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meiqun Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiqun Cao. The network helps show where Meiqun Cao may publish in the future.

Co-authorship network of co-authors of Meiqun Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Meiqun Cao. A scholar is included among the top collaborators of Meiqun Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meiqun Cao. Meiqun Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 9
4
Nanomedicine in cancer therapybreakdown →
447
5 0
6 6
7 7
8 35
9 14
10 33
11 12
12 29
13 73
14 49
15 52
16 11
17 52
18 9
19 1
20 28

About Meiqun Cao

Meiqun Cao is a scholar working on Biological Psychiatry, Pharmacology and Complementary and alternative medicine, having authored 23 papers that have together received 900 indexed citations. Recurring topics across this work include Traditional Chinese Medicine Studies (3 papers), Alzheimer's disease research and treatments (3 papers) and Salivary Gland Disorders and Functions (3 papers). The work is most often cited by research in Biomaterials (198 citations), Complementary and alternative medicine (71 citations) and Pharmacology (70 citations). Meiqun Cao has collaborated with scholars based in China, Hong Kong and Lebanon. Frequent co-authors include Dahua Fan, Yongkai Cao, Tao Gong, Yajun Wang, Yongliang Cao, Zhengzhi Wu, Min Ma, Qiang Zeng, Jin Yu and Wing Sum Siu. Their work appears in journals such as Frontiers in Immunology, Frontiers in Microbiology and International Journal of Biological Macromolecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026